Dawn of the hybrid immunity era in long-term care facilities

[1]  H. D. de Melker,et al.  Protection of COVID-19 vaccination and previous infection against Omicron BA.1, BA.2 and Delta SARS-CoV-2 infections , 2022, Nature Communications.

[2]  A. Copas,et al.  Duration of vaccine effectiveness against SARS-CoV-2 infection, hospitalisation, and death in residents and staff of long-term care facilities in England (VIVALDI): a prospective cohort study , 2022, The Lancet Healthy Longevity.

[3]  Gheyath K Nasrallah,et al.  Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections , 2022, The New England journal of medicine.

[4]  J. Wohlfahrt,et al.  Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study , 2022, medRxiv.

[5]  C. del Rio,et al.  COVID-19 in 2022-The Beginning of the End or the End of the Beginning? , 2022, JAMA.

[6]  Michael I. Mandel,et al.  Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2 , 2022, The New England journal of medicine.

[7]  S. Buchan,et al.  Effectiveness of a Fourth Dose of COVID-19 Vaccine among Long-Term Care Residents in Ontario, Canada , 2022, medRxiv.

[8]  N. Andrews,et al.  Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines , 2022, The New England journal of medicine.

[9]  K. Bruxvoort,et al.  Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants , 2022, Nature Medicine.

[10]  T. Peto,et al.  Effect of Covid-19 Vaccination on Transmission of Alpha and Delta Variants , 2022, The New England journal of medicine.